BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30919222)

  • 1. ABT-263 exhibits apoptosis-inducing potential in oral cancer cells by targeting C/EBP-homologous protein.
    Yang IH; Jung JY; Kim SH; Yoo ES; Cho NP; Lee H; Lee JY; Hong SD; Shin JA; Cho SD
    Cell Oncol (Dordr); 2019 Jun; 42(3):357-368. PubMed ID: 30919222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting ERK1/2-bim signaling cascades by BH3-mimetic ABT-737 as an alternative therapeutic strategy for oral cancer.
    Shin JA; Kim LH; Lee SJ; Jeong JH; Jung JY; Lee HN; Hong IS; Cho SD
    Oncotarget; 2015 Nov; 6(34):35667-83. PubMed ID: 26447615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.
    Hari Y; Harashima N; Tajima Y; Harada M
    Oncotarget; 2015 Dec; 6(39):41902-15. PubMed ID: 26506422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABT-263 enhances sorafenib-induced apoptosis associated with Akt activity and the expression of Bax and p21((CIP1/WAF1)) in human cancer cells.
    Li J; Chen Y; Wan J; Liu X; Yu C; Li W
    Br J Pharmacol; 2014 Jul; 171(13):3182-95. PubMed ID: 24571452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sorafenib potentiates ABT-737-induced apoptosis in human oral cancer cells.
    Kim LH; Shin JA; Jang B; Yang IH; Won DH; Jeong JH; Chung TH; Cho NP; Cho SD
    Arch Oral Biol; 2017 Jan; 73():1-6. PubMed ID: 27632413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer.
    Chen Q; Song S; Wei S; Liu B; Honjo S; Scott A; Jin J; Ma L; Zhu H; Skinner HD; Johnson RL; Ajani JA
    Oncotarget; 2015 Sep; 6(28):25883-96. PubMed ID: 26317542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of ABT-263 activity across a cancer cell line collection leads to a potent combination therapy for small-cell lung cancer.
    Faber AC; Farago AF; Costa C; Dastur A; Gomez-Caraballo M; Robbins R; Wagner BL; Rideout WM; Jakubik CT; Ham J; Edelman EJ; Ebi H; Yeo AT; Hata AN; Song Y; Patel NU; March RJ; Tam AT; Milano RJ; Boisvert JL; Hicks MA; Elmiligy S; Malstrom SE; Rivera MN; Harada H; Windle BE; Ramaswamy S; Benes CH; Jacks T; Engelman JA
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):E1288-96. PubMed ID: 25737542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABT-263 induces G
    Lin QH; Que FC; Gu CP; Zhong DS; Zhou D; Kong Y; Yu L; Liu SW
    Acta Pharmacol Sin; 2017 Dec; 38(12):1632-1641. PubMed ID: 28713162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy.
    Ritter V; Krautter F; Klein D; Jendrossek V; Rudner J
    Cell Death Dis; 2021 Jul; 12(7):694. PubMed ID: 34257274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis.
    Simonin K; N'Diaye M; Lheureux S; Loussouarn C; Dutoit S; Briand M; Giffard F; Brotin E; Blanc-Fournier C; Poulain L
    Apoptosis; 2013 Apr; 18(4):492-508. PubMed ID: 23344663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corosolic acid, a natural triterpenoid, induces ER stress-dependent apoptosis in human castration resistant prostate cancer cells via activation of IRE-1/JNK, PERK/CHOP and TRIB3.
    Ma B; Zhang H; Wang Y; Zhao A; Zhu Z; Bao X; Sun Y; Li L; Zhang Q
    J Exp Clin Cancer Res; 2018 Sep; 37(1):210. PubMed ID: 30176898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis induced by caffeic acid phenethyl ester in human oral cancer cell lines: Involvement of Puma and Bax activation.
    Yu HJ; Shin JA; Yang IH; Won DH; Ahn CH; Kwon HJ; Lee JS; Cho NP; Kim EC; Yoon HJ; Lee JI; Hong SD; Cho SD
    Arch Oral Biol; 2017 Dec; 84():94-99. PubMed ID: 28965045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting CDK9 by wogonin and related natural flavones potentiates the anti-cancer efficacy of the Bcl-2 family inhibitor ABT-263.
    Polier G; Giaisi M; Köhler R; Müller WW; Lutz C; Buss EC; Krammer PH; Li-Weber M
    Int J Cancer; 2015 Feb; 136(3):688-98. PubMed ID: 24895203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engeletin suppresses lung cancer progression by inducing apoptotic cell death through modulating the XIAP signaling pathway: A molecular mechanism involving ER stress.
    Liu T; Li Y; Sun J; Tian G; Shi Z
    Biomed Pharmacother; 2020 Aug; 128():110221. PubMed ID: 32447208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fucoidan induces Toll-like receptor 4-regulated reactive oxygen species and promotes endoplasmic reticulum stress-mediated apoptosis in lung cancer.
    Hsu HY; Lin TY; Lu MK; Leng PJ; Tsao SM; Wu YC
    Sci Rep; 2017 Mar; 7():44990. PubMed ID: 28332554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of apoptosis repressor with a CARD domain (ARC) in the therapeutic resistance of renal cell carcinoma (RCC): the crucial role of ARC in the inhibition of extrinsic and intrinsic apoptotic signalling.
    Toth C; Funke S; Nitsche V; Liverts A; Zlachevska V; Gasis M; Wiek C; Hanenberg H; Mahotka C; Schirmacher P; Heikaus S
    Cell Commun Signal; 2017 May; 15(1):16. PubMed ID: 28464919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABT-737 Synergizes with Cisplatin Bypassing Aberration of Apoptotic Pathway in Non-small Cell Lung Cancer.
    Kim EY; Jung JY; Kim A; Chang YS; Kim SK
    Neoplasia; 2017 Apr; 19(4):354-363. PubMed ID: 28319809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic cooperation between ABT-263 and MEK1/2 inhibitor: effect on apoptosis and proliferation of acute myeloid leukemia cells.
    Airiau K; Prouzet-Mauléon V; Rousseau B; Pigneux A; Jeanneteau M; Giraudon M; Allou K; Dubus P; Belloc F; Mahon FX
    Oncotarget; 2016 Jan; 7(1):845-59. PubMed ID: 26625317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clitocine induces apoptosis and enhances the lethality of ABT-737 in human colon cancer cells by disrupting the interaction of Mcl-1 and Bak.
    Sun JG; Xiang J; Zeng XL; Li X; Wu P; Fung KP; Liu FY
    Cancer Lett; 2014 Dec; 355(2):253-63. PubMed ID: 25304383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycycoumarin Sensitizes Liver Cancer Cells to ABT-737 by Targeting De Novo Lipogenesis and TOPK-Survivin Axis.
    Zhang E; Yin S; Lu X; Ye L; Fan L; Hu H
    Nutrients; 2018 Mar; 10(3):. PubMed ID: 29543705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.